AnaptysBio, Inc. (ANAB)
Company Info
| ISIN | US0327241065 |
|---|---|
| CUSIP | 032724106 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $377.37M |
|---|---|
| EPS | -$5.42 |
| Revenue (TTM) | $14.96M |
| Gross Profit (TTM) | -$78.51M |
| EBITDA (TTM) | -$150.78M |
| Year Range | $13.56 - $32.44 |
| Target Price | $26.25 |
| Short % | 27.97% |
| Short Ratio | 24.34 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in AnaptysBio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: ANAB vs. VOO
Return
AnaptysBio, Inc. had a return of -53.89% year-to-date (YTD) and -48.87% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -53.89% | 18.75% |
| 1 month | -18.90% | 8.90% |
| 6 months | -23.38% | 8.42% |
| 1 year | -48.87% | 13.21% |
| 5 years (annualized) | -28.06% | 11.63% |
| 10 years (annualized) | N/A | 9.74% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -4.32% | -8.26% | 6.49% | -3.10% | -0.15% | -8.74% | -9.19% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for AnaptysBio, Inc. (ANAB) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ANAB AnaptysBio, Inc. | -0.92 | ||||
^GSPC S&P 500 | 0.98 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the AnaptysBio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AnaptysBio, Inc. was 92.08%, occurring on Nov 8, 2019. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.08% | Mar 5, 2018 | 426 | Nov 8, 2019 | — | — | — |
| -32.97% | Mar 31, 2017 | 47 | Jun 7, 2017 | 32 | Jul 24, 2017 | 79 |
| -32.31% | Jul 25, 2017 | 16 | Aug 15, 2017 | 15 | Sep 6, 2017 | 31 |
| -14.04% | Jan 25, 2018 | 8 | Feb 5, 2018 | 7 | Feb 14, 2018 | 15 |
| -10.4% | Oct 13, 2017 | 4 | Oct 18, 2017 | 18 | Nov 13, 2017 | 22 |
Volatility Chart
The current AnaptysBio, Inc. volatility is 17.42%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.